Barry has 40 years of experience in the life science industry, including investment research, strategic planning, company formation, licensing/mergers/acquisitions, and marketing.
Huron Consulting Group – Managing Director, Life Sciences
Assumed Life Science leadership role following the successful sale of Frankel Group LLC to Huron Consulting Group. Engagements spanned the life science industry, and included repurposing/reformulation strategy for ANDA and 505(b)2 designations; global regenerative medicine and specialty dermatology strategies, including business definition, structure, LM&A targets, and development strategy; and a range of new business formations and business model structures.
Frankel Group LLC – Founder & Managing Director
Founder of $20M, 50+ professional life science strategy consulting firm. Offices in New York NY, Cambridge, MA, Tel Aviv IS with global alliances. Engagements were across the industry, and included novel academic medical center/emerging R&D partnership strategy; restructuring, followed by board membership and ultimate sale of oncology therapeutics/diagnostics company; biologics company formation, funding, business strategy, joint venture strategy, and ultimate sale.
S.J. Weinstein Associates, INC – President and Partner
President of $30M billings healthcare marketing strategy and communications firm. Increased revenues over six-fold during a 10-year period; expanded firm product from core advertising to public relations, medical education, and strategic marketing consulting.
Pfizer Pharmaceuticals – Branded & Generic Anti-Infectives, Diagnostics Marketing; Strategic Planning
Marketing management of ethical and multi-source anti-infective product lines; launched third-generation cephalosporin achieving leading share in the category, and developed first wholesaler partnership marketing program for multi-source products. Marketing and new product development of microbiology instrument and reagent line; supervised National Accounts and Technical Support; relaunched instrument line and increased placements 250%. Business planning, licensing and acquisitions of diagnostic products business; divested imaging and clinical laboratory businesses via trade sales.
Citibank Investment Management Group – Senior Research Officer
Equity investment recommendations for a $1B fund in life sciences; outperformance versus industry averages, 40% increase in fund allocation to 3X S&P 500 weighting.
Master of Business Administration, Finance, with Distinction, The Wharton School, University of Pennsylvania
Bachelor of Science, Engineering, Summa Cum Laude, College of Engineering, Rutgers University
Board Member Nanocare Technologies, Advisor Marathon Asset Management
Advisor, Rutgers Center for Innovation and Emerging Technology (CIVET)
Chairman, Wainscott (New York) Community Advisory Council